NCT05950022 Clinical Improvement Obtained by Endoscopic Ilio-Psoas Tenotomy (Lesser Trochanter Versus Acetabular Notch)
| NCT ID | NCT05950022 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Condition | Tendinopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 108 participants |
| Start Date | 2023-12-19 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 108 participants in total. It began in 2023-12-19 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to assess Oxford Hip Score at baseline, at 2 months and at over 12 months.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years old; * Definite diagnosis of iliopsoas tendinopathy due to conflict between the tendon and the prosthetic cup; * Failure of first-line conservative treatment; * Planned endoscopic tenotomy; * Affiliation to the social security scheme; * Signed informed consent. Exclusion Criteria: * Revision total hip prosthesis, multiple operations prior to tenotomy; * Other surgical or medical interventions planned during the study; * Participation in another clinical trial, or during a period of exclusion from another clinical trial; * Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding; * Patient deprived of liberty or under guardianship or curatorship or unable to give consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05950022 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tendinopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05950022 currently recruiting?
Yes, NCT05950022 is actively recruiting participants. Contact the research team at n.bonin@gmail.com for enrollment information.
Where is the NCT05950022 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT05950022 clinical trial?
NCT05950022 is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. The trial plans to enroll 108 participants.